Modified Hyaluronic Acid Joint Injection for Chronic Pain Relief
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for osteoarthritis and rheumatoid arthritis, particularly those involving injections, impose a significant physical and psychological burden on patients due to frequent administration requirements, which is burdensome for chronic symptoms lasting 12 weeks or more, and existing methods fail to provide adequate long-term pain relief.
Innovation Solution
A composition containing modified hyaluronic acid with a covalently bonded anti-inflammatory compound, administered as an injection every four weeks or more, which provides sustained pain relief and improved joint function without the need for frequent injections.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If steroids or non-steroidal anti-inflammatory compounds are administered frequently to maintain sufficient medicinal effect, then pain relief effectiveness is improved, but patient burden and compliance deteriorate
Solution Approach 1:
The patent combines hyaluronic acid (which provides long-lasting joint lubrication and structural support) with anti-inflammatory compounds (steroids or non-steroidal anti-inflammatory drugs) into a single injection formulation. This merging allows the anti-inflammatory component to provide immediate pain relief while the hyaluronic acid component ensures sustained therapeutic effect, eliminating the need for frequent separate administrations of anti-inflammatory drugs.
Solution Approach 2:
The formulation is designed so that the anti-inflammatory compound provides immediate preliminary action upon injection to rapidly control acute inflammation and pain, while the hyaluronic acid component establishes a long-term therapeutic foundation that maintains joint function over several weeks, reducing the need for repeated interventions.
2Duration of action of moving object
If injections are administered frequently to treat chronic joint disease, then medicinal effect is maintained, but physical and psychological burden on patient increases
Solution Approach 1:
By merging hyaluronic acid (providing sustained structural support and lubrication for several weeks) with anti-inflammatory compounds in a single injection, the formulation achieves both immediate and long-term therapeutic effects, reducing the frequency of required administrations and thereby decreasing patient burden.
Solution Approach 2:
The combined formulation ensures continuous therapeutic action through the synergistic effects of both components: the anti-inflammatory compound addresses acute symptoms immediately, while the hyaluronic acid maintains joint function continuously over several weeks, providing uninterrupted therapeutic coverage without requiring frequent re-administration.
Data Source
AI summary
The present invention pertains to a composition for treating joint diseases and a kit including the same, and the purpose of the present invention is to provide a composition for treating joint diseases which can be used in patients with joint diseases, and a kit which includes the same. The present invention minimizes the burden on patients with chronic joint diseases while also achieving excellent medicinal effects by means of a composition for treating joint diseases which includes a modified hyaluronic acid having a group derived from an anti-inflammatory compound or a pharmaceutically acceptable salt of the modified hyaluronic acid, and which is used by being administered to patients with human joint diseases as a single injection per period of four or more weeks.